title: [Risk of cancer in patients following chronic dialysis and kidney graft].
abstract: BACKGROUND
  A high prevalence of renal insufficiency has been observed in cancer patients as well as a high incidence of de novo cancer in dialysis or renal transplant patients.
  
  
  METHODS
  We aimed to determine the incidence of cancer in patients under dialysis and in kidney transplant recipients through a search of the literature.
  
  
  RESULTS
  Under chronic dialysis, the risk of cancer increases from 1.1 to 1.8 in comparison to the general population. These risks reach 2.5 to 3.9 in renal transplant patients, but depend on the type of tumor.
  
  
  CONCLUSIONS
  In transplant recipients, the risk of cancer induced by immunosuppressive therapy requires a specific follow-up and a screening for any medical history of cancer in the donor and the recipient.
authors.affiliation: Hôpital de la Pitié-Salpêtrière, service ICAR, service de néphrologie, Paris, France. nicolas.janus@psl.aphp.fr
authors.forename: Nicolas
authors.initials: N
authors.lastname: Janus
authors.forename: Vincent
authors.initials: V
authors.lastname: Launay-Vacher
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Ferrero
authors.forename: Juliette
authors.initials: J
authors.lastname: Thariat
mesh_terms: D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007680:Kidney Neoplasms / Q000209:etiology; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D009369:Neoplasms / Q000209:etiology*; D006435:Renal Dialysis / Q000009:adverse effects*; D051436:Renal Insufficiency, Chronic / Q000401:mortality / Q000628:therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents